Conversely, pre-incubation of human melanoma patient-derived tumor-infiltrating lymphocytes, healthy donor-derived NK cells, and CD19-directed CAR T cells with the NRF2 activator auranofin enhance the efficacy of adoptive cell therapy [166]. The gene discussed is NFE2L2; the disease is neoplasm.